The burden of rheumatoid arthritis and access to treatment: health burden and costs
作者： J. Lundkvist , F. Kastäng , G. Kobelt
DOI: 10.1007/S10198-007-0088-8
关键词: Quality-adjusted life year 、 Quality of life 、 Total cost 、 Health economics 、 Economic growth 、 Environmental health 、 Medicine 、 Global health 、 Arthritis 、 Economic impact analysis 、 Public health
摘要: … arthritis and patient access to treatment”, this paper reviews evidence on the health burden of … (% of deaths attributable to RA) and quality of life (utility and loss of QALYs), as well as the …
springer.com
jstor.org 
sci-hub.se 参考文章(71)
Bernard S. Bloom, Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis The American Journal of Medicine. ,vol. 84, pp. 20- 24 ,(1988) , 10.1016/0002-9343(88)90250-1
Bernard S. Bloom, Douglas J. Bruno, Daniel Y. Maman, Ravi Jayadevappa, Usefulness of US cost-of-illness studies in healthcare decision making. PharmacoEconomics. ,vol. 19, pp. 207- 213 ,(2001) , 10.2165/00019053-200119020-00007
Elizabeth K. Rasch, Rosemarie Hirsch, Ryne Paulose-Ram, Marc C. Hochberg, Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classification Arthritis & Rheumatism. ,vol. 48, pp. 917- 926 ,(2003) , 10.1002/ART.10897
J.L. Hülsemann, J. Ruof, H. Zeidler, T. Mittendorf, Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'. Rheumatology International. ,vol. 26, pp. 704- 711 ,(2006) , 10.1007/S00296-005-0070-7
Astrid MJ Chorus, Harald S Miedema, Cees J Wevers, Sjef van der Linden, Labour force participation among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. ,vol. 59, pp. 549- 554 ,(2000) , 10.1136/ARD.59.7.549
P. Sobocki, M. Pugliatti, K. Lauer, G. Kobelt, Estimation of the cost of MS in Europe: extrapolations from a multinational cost study. Multiple Sclerosis Journal. ,vol. 13, pp. 1054- 1064 ,(2007) , 10.1177/1352458507077941
S. Merkesdal, J. Ruof, O. Sch�ffski, K. Bernitt, H. Zeidler, W. Mau, Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis & Rheumatism. ,vol. 44, pp. 528- 534 ,(2001) , 10.1002/1529-0131(200103)44:3<528::AID-ANR100>3.0.CO;2-U
Gisela Kobelt, Linus Jönsson, Peter Lindgren, Adam Young, Kerstin Eberhardt, Modeling the progression of rheumatoid arthritis: A two‐country model to estimate costs and consequences of rheumatoid arthritis Arthritis & Rheumatism. ,vol. 46, pp. 2310- 2319 ,(2002) , 10.1002/ART.10471
A Young, J Dixey, E Kulinskaya, N Cox, P Davies, J Devlin, P Emery, A Gough, D James, P Prouse, P Williams, J Winfield, Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS) Annals of the Rheumatic Diseases. ,vol. 61, pp. 335- 340 ,(2002) , 10.1136/ARD.61.4.335
A. Young, J. Dixey, N. Cox, P. Davies, J. Devlin, P. Emery, S. Gallivan, A. Gough, D. James, P. Prouse, P. Williams, J. Winfield, How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow‐up in 732 patients from the Early RA Study (ERAS) Rheumatology. ,vol. 39, pp. 603- 611 ,(2000) , 10.1093/RHEUMATOLOGY/39.6.603